RIGENERAND S R L has a total of 17 patent applications. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology and pharmaceuticals are WILSON WOLF MFG, FUZHOU DA BEI NONG BIOTECH CO LTD and NBIOTEK INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | United States | 2 | |
#6 | China | 1 | |
#7 | Italy | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Microbiology | |
#4 | Peptides | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Dominici Massimo | 17 |
#2 | Candini Olivia | 14 |
#3 | Grisendi Giulia | 9 |
#4 | Spano Carlotta | 9 |
#5 | Rossignoli Filippo | 8 |
#6 | Brogli Matteo | 7 |
#7 | Mari Giorgio | 5 |
#8 | Conte Pierfranco | 2 |
#9 | Bellini Gianni | 2 |
#10 | Cafarelli Luigi | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020026284A1 | Method for the production of bi-functional cells to treat neoplasia | |
EP3801576A1 | Method to produce conditionally apoptotic cells | |
AU2019260693A1 | Method for the production of cellular particulate with antitumor activity | |
CN111819277A | Device, kit and method for three-dimensional cell culture |